CIK 0001472012
- Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770694340
- Phone
- +1 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $334,224
- in 1 filing, $334K under 10b5-1 plans
Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | Lefenfeld Michael Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | ||
| 2023-01-15 | Lefenfeld Michael Director | Grant or award | +13,875 | $4.00 | $56K | 40,747 |
| 2022-06-16 | Lefenfeld Michael Director | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | ||
| 2021-05-28 | Lefenfeld Michael Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2021-05-26 | Lefenfeld Michael Director | Purchase | +1,335 | $19.03 | $25K | 26,872 |
| 2021-05-25 | Lefenfeld Michael Director | Purchase | +2,715 | $18.44 | $50K | 25,537 |
| 2021-05-24 | Lefenfeld Michael Director | Purchase | +600 | $17.80 | $11K | 22,822 |
| 2020-11-03 | Lefenfeld Michael Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2020-10-06 | Lefenfeld Michael Director | Conversion | +22,222 | 22,222 | ||
| 2020-10-06 | Lefenfeld Michael Director | Conversion · Series A Convertible Preferred Stock | −22,222 | 0 | ||
| 2020-10-06 | Lefenfeld Michael Director | Conversion · Warrant (right to buy) | −11,111 | 0 | ||
| 2020-10-06 | Lefenfeld Michael Director | Conversion · Warrant (right to buy) | +11,111 | 11,111 |
Page 1 of 1 · 12 trades